Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Amgen wins patent appeal on psoriasis drug Otzela against Zydus Pharma (USA), Sandoz

Ruchika Sharma22 April 2023 1:30 PM IST

Thousand Oaks: Amgen has announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District...

Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, Europe

Dr Reddy's Labs unveils Treprostinil Injection in US

Ruchika Sharma22 April 2023 12:30 PM IST

Hyderabad: Dr. Reddy's Laboratories Ltd. has announced the launch of Treprostinil Injection in the U.S. market, a therapeutic equivalent generic ...

Janssen-Cilag Guselkumab receives UK nod for Crohns disease, ulcerative colitis

Janssen gets European Commission nod for AKEEGA to treat metastatic castration resistant prostate cancer with BRCA1/2 mutations

Ruchika Sharma22 April 2023 11:32 AM IST

The EC authorisation, which also marks the first worldwide approval for AKEEGA, is based on results of the randomised, double-blind, placebo...

Siemens Healthineers unveils new manufacturing facility for MRI machines at Bengaluru

Ruchika Sharma21 April 2023 3:15 PM IST

The new facility is approved under the Radiology and Imaging Medical devices segment of the Production Linked Incentive Scheme by the Government of...

USFDA nod to JnJ Tremfya for Crohns disease

US judge halts most talc lawsuits against Johnson and Johnson

Ruchika Sharma21 April 2023 2:15 PM IST

LTL Management argued that allowing litigation against J&J to continue would imperil current settlement efforts.

SII in talks on fill finishing Oxford University R21 malaria vaccine in Ghana: Expert

Ruchika Sharma21 April 2023 1:15 PM IST

Bengaluru: Vaccine manufacturer Serum Institute of India is holding talks on fill-finishing Oxford University's R21 malaria vaccine in Ghana, which...

CCI approves acquisition of up to 76.10 percent of voting share capital of Suven Pharma by Berhyanda

Ruchika Sharma21 April 2023 12:15 PM IST

New Delhi: Anti-trust regulator Competition Commission of India (CCI) approves the acquisition of up to 76.10% of the voting share capital of...

Natco Pharma net profit down 23.44 percent at Rs 517.9 crore in Q2

Natco Pharma to set up subsidiary in Indonesia with investment of Rs 25 crore

Ruchika Sharma21 April 2023 11:15 AM IST

Natco will initially invest USD 1 million for a stake of 51 per cent as capital contribution and balance will be invested as and when the funds are...

USFDA authorizes second Omicron-updated COVID booster for older adults

Ruchika Sharma20 April 2023 4:30 PM IST

US: The U.S. Food and Drug Administration on Tuesday authorized a second dose of Omicron-targeting COVID-19 vaccines for older adults as well as those...

CDSCO Panel Directs Abbott to Incorporate New Safety, Follow-up Measures in Clarithromycin Study

Abbott signals recovery in device sales as hospital staff shortages ease

Ruchika Sharma20 April 2023 3:30 PM IST

United States: Abbott Laboratories said on Wednesday most delayed non-urgent medical procedures had resumed globally three years into the...

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

USFDA nod to Roche's Polivy in combination with R-CHP for certain types of previously untreated diffuse large B-cell lymphoma

Ruchika Sharma20 April 2023 2:30 PM IST

Polivy is a first-in-class anti-CD79b antibody-drug conjugate.

Sanofi to buy Vigil Neuroscience in USD 470 million deal

Marksans Pharma concludes acquisition of Tevapharm India's Goa manufacturing site

Ruchika Sharma20 April 2023 1:30 PM IST

The acquired facility will enable Marksans Pharma to potentially double the existing Indian capacity from 8bn units per annum currently.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok